Lilly settles Zyprexa marketing lawsuit
Pharmaceutical company Eli Lilly & Co. has agreed to settle a product liability lawsuit brought by a state claiming that the company improperly marketed its antipsychotic Zyprexa. Lilly settled a marketing investigation in January and has now settled another lawsuit.
To read more about the Zyprexa lawsuit settlement.
